
| Element | AllowableQualifiersList |
<xs:element name="AllowableQualifier"> <xs:complexType> <xs:sequence> <xs:element ref="QualifierReferredTo"/> <xs:element ref="Abbreviation"/> </xs:sequence> </xs:complexType> </xs:element> |
|
Q000031 |
|
analogs & derivatives |
|
AA |
|
Q000276 |
|
immunology |
|
IM |
|
Q000493 |
|
pharmacokinetics |
|
PK |
|
Q000096 |
|
biosynthesis |
|
BI |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000506 |
|
poisoning |
|
PO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000819 |
|
agonists |
|
AG |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000138 |
|
chemical synthesis |
|
CS |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000037 |
|
antagonists & inhibitors |
|
AI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |